Kevin Hourican Form 3 CVS HEALTH / Kevin Hourican ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Hourican Kevin

(Last) (First) (Middle)

ONE CVS DRIVE

(Street)

WOONSOCKET RI 02895

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/04/2018

3. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
EVP & President, CVS Pharmacy

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,709	D
Common Stock (restricted)	1,232(1)	D
Common Stock (restricted)	399(2)	D
Common Stock (restricted)	840(3)	D
Common Stock (restricted)	2,444(4)	D
Common Stock (restricted)	2,146(5)	D
Common Stock (restricted)	3,523(6)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	04/01/2014(7)	04/01/2020	Common Stock	4,426	54.53	D
Stock Option	04/01/2015(8)	04/01/2021	Common Stock	9,442	74.29	D
Stock Option	04/01/2016(9)	04/01/2022	Common Stock	17,822	102.26	D
Stock Option	04/01/2017(10)	04/01/2023	Common Stock	17,611	104.82	D
Stock Option	04/03/2018(11)	04/03/2024	Common Stock	30,169	78.05	D
Stock Option	04/01/2019(12)	04/01/2025	Common Stock	87,575	62.21	D

Explanation of Responses:

1. Consists of remaining Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commening 2/28/2019.

2. Consists of remaining Restricted Stock Units awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, under its 2010 Incentive Compensation Plan. Restrictions lapse 2/28/2019.

3. Consists of remaining Restricted Stock Units awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, under its 2010 Incentive Compensation Plan. Restrictions lapse in two equal installments on 2/28/2019 and 2/28/2020.

4. Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/1/2019.

5. Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/1/2020.

6. Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/3/2021.

7. Remaining options became exercisable in four equal annual installments beginning on 4/1/2014.

8. Remaining options became exercisable in four equal annual installments beginning on 4/1/2015.

9. Option became exercisable in four equal annual installments beginning on 4/1/2016.

10. Option became exercisable in four equal annual installments beginning on 4/1/2017.

11. Option became exercisable in four equal annual installments beginning on 4/3/2018.

12. Option becomes exercisable in four equal annual installments beginning on 4/1/2019.

	/s/ Kevin P. Hourican	06/08/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.